Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies. (2013)
Attributed to:
A systematic investigation into the pathogenesis and course of Parkinson's syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1042/bj20121742
PubMed Identifier: 23560750
Publication URI: http://europepmc.org/abstract/MED/23560750
Type: Journal Article/Review
Volume: 453
Parent Publication: The Biochemical journal
Issue: 1
ISSN: 0264-6021